Ligenesis at the 2025 Moscow Photonics Exhibition and China–Russia laser-medical forum
As the only invited Chinese medical-laser enterprise, Ligenesis presented clinical innovation in women’s health and respiratory intervention.
The 2025 Moscow International Photonics Exhibition was held from 1 to 7 April at the Moscow Central Exhibition Centre. On 3 April, the 15th China–Russia Laser Industry Forum and first China–Russia Laser Medical Application Seminar brought together specialists from both countries.
A Ligenesis delegation led in part by women’s-health director Tong Chengliang attended as the only invited Chinese medical-laser enterprise. Wuhan officials, Huazhong University of Science and Technology representatives and Russian laser specialists discussed clinical translation and international cooperation.
The obstetrics and gynaecology programme covered minimally invasive treatment for stress urinary incontinence, hysteroscopic myoma removal, vulvar disease and functional reconstruction. Specialists recognised the Fuhao MF multi-focus laser system for controlled thermal effects, tissue protection and the integration of function with aesthetics.
In the respiratory-intervention programme, Chinese and Russian experts reviewed laser treatment for airway tuberculosis, paediatric tracheal stenosis and other complex lesions. The Ligenesis laser knife was highlighted for stable energy control, rapid vaporisation and precise minimally invasive ablation.
Ligenesis medical department representative Liu Yue also presented the use of lasers in serious medical care, including lung-cancer ablation and airway reconstruction. The meeting created new links for China–Russia cooperation and for bringing Chinese medical-laser innovation to broader clinical use.